Abstract
Aim:
To determine whether ginsenosides with various sugar attachments may act as active components responsible for the cardiac therapeutic effects of ginseng and sanqi (the roots of Panax ginseng and Panax notoginseng) via the same molecular mechanism triggered by cardiac glycosides, such as ouabain and digoxin.
Methods:
The structural similarity between ginsenosides and ouabain was analyzed. The inhibitory potency of ginsenosides and ouabain on Na+/K+-ATPase activity was examined and compared. Molecular modeling was exhibited for the docking of ginsenosides to Na+/K+-ATPase.
Results:
Ginsenosides with sugar moieties attached only to the C-3 position of the steroid-like structure, equivalent to the sugar position in cardiac glycosides, and possessed inhibitory potency on Na+/K+-ATPase activity. However, their inhibitory potency was significantly reduced or completely abolished when a monosaccharide was linked to the C-6 or C-20 position of the steroid-like structure; replacement of the monosaccharide with a disaccharide molecule at either of these positions caused the disappearance of the inhibitory potency. Molecular modeling and docking confirmed that the difference in Na+/K+-ATPase inhibitory potency among ginsenosides was due to the steric hindrance of sugar attachment at the C-6 and C-20 positions of the steroid-like structure.
Conclusion:
The cardiac therapeutic effects of ginseng and sanqi should be at least partly attributed to the effective inhibition of Na+/K+-ATPase by their metabolized ginsenosides with sugar moieties attached only to the C-3 position of the steroid-like structure.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Sengupta S, Toh SA, Sellers LA, Skepper JN, Koolwijk P, Leung HW, et al. Modulating angiogenesis: the yin and the yang in ginseng. Circulation 2004; 110: 1219–25.
Lei XL, Chiou GC . Cardiovascular pharmacology of Panax notoginseng (Burk) F. H. Chen and Salvia miltiorrhiza. Am J Chin Med 1986; 14: 145–52.
Wei JX, Du YC . Modern science research and application of Panax notoginseng. Kunming: Yunnan Science and Technology Press;1996 (in Chinese).
Cicero AF, Vitale G, Savino G, Arlett R . Panax notoginseng (Burk.) effects on fibrinogen and lipid plasma level in rats fed on a high-fat diet. Phytother Res 2003; 17: 174–8.
Dong TT, Cui XM, Song ZH, Zhao KJ, Ji ZN, Lo CK, et al. Chemical assessment of roots of Panax notoginseng in China: regional and seasonal variations in its active constituents. J Agric Food Chem 2003; 51: 4617–23.
Leung KS, Chan K, Bensoussan A, Munroe MJ . Application of atmospheric pressure chemical ionisation mass spectrometry in the identification and differentiation of Panax species. Phytochem Anal 2007; 18: 146–50.
Hasegawa H . Proof of the mysterious efficacy of ginseng: basic and clinical trials: metabolic activation of ginsenoside: deglycosylation by intestinal bacteria and esterification with fatty acid. J Pharmacol Sci 2004; 95: 153–7.
Nah SY, Kim DH, Rhim H . Ginsenosides: are any of them candidates for drugs acting on the central nervous system? CNS Drug Rev 2007; 13: 381–404.
Zhu S, Zou K, Cai S, Meselhy MR, Komatsu K . Simultaneous determination of triterpene saponins in ginseng drugs by high-performance liquid chromatography. Chem Pharm Bull 2004; 52: 995–8.
Dan M, Su M, Gao X, Zhao T, Zhao A, Xie G, et al. Metabolite profiling of Panax notoginseng using UPLC-ESI-MS. Phytochemistry 2008; 69: 2237–44.
Jiang Y, Liu W, Wang XM, Zhong GG, Zhang WJ, Chen L, et al. Calcium channel blockade and anti-free-radical actions of panaxatriol saponins in cultured myocardiocytes. Acta Pharmacol Sin 1996; 17: 138–41.
Li-Saw-Hee FL, Lip GY . Digoxin revisited. QJM 1998; 91: 259–64.
Lin SC, Way EL . A high affinity Ca2+-ATPase enriched nerve-ending plasma membranes. Brain Res 1982; 235: 387–92.
Goldberg H, Fernandez A . Simplified method of the estimation of inorganic phosphorus in body fluids. Clin Chem 1966; 12: 871–82.
Morth JP, Pedersen BP, Toustrup-Jensen MS, Sørensen TL, Petersen J, Andersen JP, et al. Crystal structure of the sodium-potassium pump. Nature 2007; 450: 1043–9.
Brooks BR, Bruccoleri RE, Olafson BD, States DJ, Swaminathan S, Karplus M . CHARMM: a program for macromolecular energy minimization and dynamics calculations. J Comp Chem 1983; 4: 187–217.
Liu LY, Koenderink JB, Swarts HG, Willems PH, De Pont JJ . Phe783, Thr797, and Asp804 in transmembrane hairpin M5-M6 of Na+,K+-ATPase play a key role in ouabain binding. J Biol Chem 2003; 278: 47240–4.
Qiu LY, Krieger E, Schaftenaar G, Swarts HG, Willems PH, De Pont JJ, et al. Reconstruction of the complete ouabain-binding pocket of Na,K-ATPase in gastric H, K-ATPase by substitution of only seven amino acids. J Biol Chem 2005; 280: 32 349–55.
Dixon SL, Merz KM Jr . One-dimensional molecular representations and similarity calculations: methodology and validation. J Med Chem 2001; 44: 3795–809.
Rao SN, Head MS, Kulkarni A, LaLonde JM . Validation studies of the site-directed docking program LibDock. J Chem Inf Model 2007; 47: 2159–71.
Diller DJ, Merz KM Jr . High throughput docking for library design and library prioritization. Proteins 2001; 43: 113–24.
Willett P, Barnard JM, Downs GM . Chemical similarity searching. J Chem Inf Comput Sci 1998; 38: 983–96.
Schultheis PJ, Wallick ET, Lingrel JB . Kinetic analysis of ouabain binding to native and mutated forms of Na, K-ATPase and identification of a new region involved in cardiac glycoside interactions. J Biol Chem 1993; 268: 22 686–94.
Kobashi K, Akao T . Relation of intestinal bacteria to pharmacological effects of glycosides. Biosci Microflora 1997; 16: 1–7.
Tawab MA, Bahr U, Karas M, Wurglics M, Schubert-Zsilavecz M . Degradation of ginsenosides in humans after oral administration. Drug Metab Dispos 2003; 31: 1065–71.
Wang JK, Portbury S, Thomas MB, Barney S, Ricca DJ, Morris DL, et al. Cardiac glycosides provide neuroprotection against ischemic stroke: discovery by a brain slice-based compound screening platform. Proc Natl Acad Sci USA 2006; 103: 10461–6.
Tzen JT, Jinn TR, Chen YC, Li FY, Cheng FC, Shi LS, et al. Magnesium lithospermate B possesses inhibitory activity on Na+,K+-ATPase and neuroprotective effects against ischemic stroke. Acta Pharmacol Sin 2007; 28: 609–15.
Zhang YG, Liu TP . Influences of ginsenosides Rb1 and Rg1 on reversible focal brain ischemia in rats. Acta Pharmacol Sin 1996; 17: 44–8.
Tian J, Fu F, Geng M, Jiang Y, Yang J, Jiang W, et al. Neuroprotective effect of 20(S)-ginsenoside Rg3 on cerebral ischemia in rats. Neurosci Lett 2005; 374: 92–7.
Zhou XM, Cao YL, Dou DQ . Protective effect of ginsenoside-Re against cerebral ischemia/reperfusion damage in rats. Biol Pharm Bull 2006; 29: 2502–5.
Yuan QL, Yang CX, Xu P, Gao XQ, Deng L, Chen P, et al. Neuroprotective effects of ginsenoside Rb1 on transient cerebral ischemia in rats. Brain Res 2007; 1167: 1–12.
Chen LM, Zhou XM, Cao YL, Hu WX . Neuroprotection of ginsenoside Re in cerebral ischemia-reperfusion injury in rats. J Asian Nat Prod Res 2008; 10: 439–45.
Acknowledgements
Project supported by a grant to Jason TC TZEN from the National Science Council, Taiwan, China (No 96-2752-B-005-008-PAE).
We thank Prof Chih-Ning SUN (Department of Entomology, National Chuang Hsing University, Taichung, Taiwan, China) for critical reading of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chen, R., Chung, Ty., Li, Fy. et al. Effect of sugar positions in ginsenosides and their inhibitory potency on Na+/K+-ATPase activity. Acta Pharmacol Sin 30, 61–69 (2009). https://doi.org/10.1038/aps.2008.6
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/aps.2008.6
Keywords
This article is cited by
-
Transcriptome analysis of Panax zingiberensis identifies genes encoding oleanolic acid glucuronosyltransferase involved in the biosynthesis of oleanane-type ginsenosides
Planta (2019)
-
Rapid preparation of rare ginsenosides by acid transformation and their structure-activity relationships against cancer cells
Scientific Reports (2015)
-
The pseudoginsenoside F11 ameliorates cisplatin-induced nephrotoxicity without compromising its anti-tumor activity in vivo
Scientific Reports (2014)
-
Detecting metabolites of different transition metallithospermate B complexes after intravenous injection in rats
Acta Pharmacologica Sinica (2014)
-
Enhancing the potency of lithospermate B for inhibiting Na+/K+-ATPase activity by forming transition metal ion complexes
Acta Pharmacologica Sinica (2013)
